Sonelokimab

• CAS Number :

  1414386-05-2

• Target :

  Interleukin|||MMP

• Related Pathways :

  Proteases/Proteasome|||Immunology/Inflammation

• Bioactivity :

  Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL) -17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C